The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Magnus was a ramper of this back in the RMS days. His usual BS of buying every day then disappeared after the price tanked.
Company doesn't give a damn about the PI that post here. About 30% of the company shares are held by 2 main shareholders now (Lanstead and Cave) so can't see us emailing Herring making any difference. The Lanstead deal gives the company an income of sorts to keep the lights on, Duffin gets his £16k p/m wage so he's happy. The wait continues.
Google shows +16%, IG Index showing -8% . who to believe?
I was going to say Nanoo = goldd
MyIPA, the share price is on its ar*e entirely due to the BoD and their (lack of) action or communications. Nothing to do with new posters being negative to get a lower entry.
Can't see any product launch from Volz or the JV happening until next year now, only a few weeks of the year left before xmas and NY shutdown. Ditto for any of the jam tomorrow deals with the 7 verticals as well. Nothing to suggest that Volz have jumped ship though, Marsh and Thornton are still with Virosynth.
Just IMO, happy get get proved wrong.
The article mentioned in the broken Directors Talk link below is from 2019...
https://www.frontiersin.org/articles/10.3389/fchem.2019.00739/full
Guess there's no point having GB Nano online shop if they don't have any products to sell. gbnano.co.uk was registered within days of the original GB Nano company being set up by Duffin but it still just links to a Ionos holding page.
Reporting to who?
Yep, that'll show em'. Like the BoD care about this message board or the investors who post on it.
Well its December 1st and nothing behind the first door. Let's hope for some Christmas cheer behind tomorrow's door. Should have bought the Aldi beer advent calendar instead.
Almost the end of the month, another £16k in wages well earned by Duffin for November.
I don't think we'll get an RNS about the JV / Volz products until Volz say so, think they're in the driving seat with that side of things. Maybe they are doing a soft launch with an existing customer, maybe still waiting for this Leach approval, maybe still working out production... who knows! Just IMO
No need to be rude NG1, Duffin never said he'd update the market in that interview, he just said they expect to get Leach approval by end October.
Duffin never said they'd update at the end of last month. The company don't update every stage of development so you may not get an RNS until the product is ready to sell or be launched by Volz, if that ever happens of course. The BOD are treating shareholders with contempt with this lack of any type of update. Definitely not a strong buy at the moment.
The company never said they were going to update the market at the end of October tbf. Duffin mentioned in an interview about waiting for Leach approval by the end of October then Volz would have what they need to start selling. That's clearly not happened yet for whatever reason. Wouldn't surprise me if we don't hear about Volz products on the market until next year.
I would have hoped that Duffin buying shares in this shambles may have improved company comms to prop up the sp, not just for his investment but the Lanstead one as well. Clearly not though. No updates, no timeline, soon be Christmas.
NNN don't have any filter products on the market yet, either through Virosynth, Volz, GB Nano or NNN directly.
"Gonna need a bigger boat" Gareth Cave, 2020
All largely irrelevent at the moment anyway as NNN no longer manufacture masks, and have no filter products on the market (yet).